10 20 30 40 50 60 70 80 2BNU - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNE SYSTEM/RECEPTOR 04-APR-05 2BNU
TITLE STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY TITLE 2 OF T CELL VACCINES
COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-CELL RECEPTOR ALPHA CHAIN C REGION; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAINS, RESIDUES 1-91; COMPND 5 SYNONYM: TCR ALPHA CHAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: T-CELL RECEPTOR BETA CHAIN C REGION; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: EXTRACELLULAR DOMAINS, RESIDUES 1-130; COMPND 11 SYNONYM: TCR BETA CHAIN; COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: IMMUNE SYSTEM; SOURCE 6 CELL: T-LYMPHOCYTE; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PGMT7; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 TISSUE: IMMUNE SYSTEM; SOURCE 16 CELL: T-LYMPHOCYTE; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 20 EXPRESSION_SYSTEM_VECTOR: PGMT7
KEYWDS SUPERAGONIST PEPTIDE T-CELL VACCINES, RECEPTOR, T-CELL, KEYWDS 2 TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE KEYWDS 3 SYSTEM/RECEPTOR
EXPDTA X-RAY DIFFRACTION
AUTHOR J.-L.CHEN,G.STEWART-JONES,G.BOSSI,N.M.LISSIN,L.WOOLDRIDGE, AUTHOR 2 E.M.L.CHOI,G.HELD,P.R.DUNBAR,R.M.ESNOUF,M.SAMI, AUTHOR 3 J.M.BOULTIER,P.J.RIZKALLAH,C.RENNER,A.SEWELL, AUTHOR 4 P.A.VAN DER MERWE,B.K.JACKOBSEN,G.GRIFFITHS,E.Y.JONES, AUTHOR 5 V.CERUNDOLO
REVDAT 3 25-NOV-15 2BNU 1 AUTHOR REMARK VERSN FORMUL REVDAT 2 24-FEB-09 2BNU 1 VERSN REVDAT 1 24-MAY-05 2BNU 0
JRNL AUTH J.-L.CHEN,G.STEWART-JONES,G.BOSSI,N.M.LISSIN, JRNL AUTH 2 L.WOOLDRIDGE,E.M.L.CHOI,G.HELD,P.R.DUNBAR, JRNL AUTH 3 R.M.ESNOUF,M.SAMI,J.M.BOULTER,P.RIZKALLAH,C.RENNER, JRNL AUTH 4 A.SEWELL,P.A.VAN DER MERWE,B.K.JAKOBSEN, JRNL AUTH 5 G.GRIFFITHS,E.Y.JONES,V.CERUNDOLO JRNL TITL STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED JRNL TITL 2 IMMUNOGENICITY OF T CELL VACCINES. JRNL REF J.EXP.MED. V. 201 1243 2005 JRNL REFN ISSN 0022-1007 JRNL PMID 15837811 JRNL DOI 10.1084/JEM.20042323
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.-L.CHEN,P.R.DUNBAR,U.GILEADI,E.JAGER,S.GNJATIC, REMARK 1 AUTH 2 Y.NAGATA,E.STOCKERT,D.L.PANICALI,Y.-T.CHEN,A.KNUTH, REMARK 1 AUTH 3 L.J.OLD,V.CERUNDOLO REMARK 1 TITL IDENTIFICATION OF NY-ESO-1 PEPTIDE ANALOGUES REMARK 1 TITL 2 CAPABLE OF IMPROVED STIMULATION OF TUMOR-REACTIVE REMARK 1 TITL 3 CTL REMARK 1 REF J.IMMUNOL. V. 165 948 2000 REMARK 1 REFN ISSN 0022-1767 REMARK 1 PMID 10878370
REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 85029 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3462 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 243 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.31 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2BNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-APR-04. REMARK 100 THE PDBE ID CODE IS EBI-23461.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85029 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1OGA REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.8
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.14750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 10820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 162 CA - CB - SG ANGL. DEV. = 9.0 DEGREES REMARK 500 CYS B 169 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 42 -167.95 -116.11 REMARK 500 SER A 59 96.69 -169.84 REMARK 500 ALA A 79 65.55 35.51 REMARK 500 ALA A 86 -176.90 176.40 REMARK 500 SER A 99 -1.75 67.15 REMARK 500 TYR A 100 -0.99 59.44 REMARK 500 ASP A 120 56.81 -149.98 REMARK 500 ARG A 128 154.87 38.23 REMARK 500 LYS A 130 13.01 130.00 REMARK 500 SER A 131 146.98 84.81 REMARK 500 SER A 132 72.24 64.20 REMARK 500 ASP A 133 -85.25 -152.65 REMARK 500 SER A 180 -154.37 -138.79 REMARK 500 LYS A 182 79.24 -3.44 REMARK 500 SER A 183 -142.97 -165.24 REMARK 500 PHE A 185 102.05 -178.86 REMARK 500 ASN A 192 33.29 -66.42 REMARK 500 SER B 86 -178.21 -174.21 REMARK 500 ASN B 97 -132.00 46.54 REMARK 500 GLU B 217 45.60 -75.73 REMARK 500 ASN B 218 -15.83 -145.09 REMARK 500 ASP B 224 36.07 -80.02 REMARK 500 REMARK 500 REMARK: NULL
DBREF 2BNU A 2 113 UNP P01848 TCA_HUMAN 2 113 DBREF 2BNU A 114 204 UNP P01848 TCA_HUMAN 1 91 DBREF 2BNU B 2 112 UNP P01848 TCA_HUMAN 2 112 DBREF 2BNU B 113 242 UNP P01850 TCB_HUMAN 1 130
SEQADV 2BNU TYR A 115 UNP P01848 ASN 2 CONFLICT SEQADV 2BNU ARG A 128 UNP P01848 ASP 15 CONFLICT SEQADV 2BNU CYS A 162 UNP P01848 THR 49 CONFLICT SEQADV 2BNU LYS B 116 UNP P01848 ASN 4 CONFLICT SEQADV 2BNU ASN B 117 UNP P01848 LYS 5 CONFLICT SEQADV 2BNU TYR B 149 UNP P01848 PHE 37 CONFLICT SEQADV 2BNU CYS B 169 UNP P01848 SER 57 CONFLICT SEQADV 2BNU ALA B 187 UNP P01848 CYS 75 CONFLICT SEQADV 2BNU ASP B 201 UNP P01848 ASN 89 CONFLICT
SEQRES 1 A 203 GLN GLU VAL THR GLN ILE PRO ALA ALA LEU SER VAL PRO SEQRES 2 A 203 GLU GLY GLU ASN LEU VAL LEU ASN CYS SER PHE THR ASP SEQRES 3 A 203 SER ALA ILE TYR ASN LEU GLN TRP PHE ARG GLN ASP PRO SEQRES 4 A 203 GLY LYS GLY LEU THR SER LEU LEU LEU ILE GLN SER SER SEQRES 5 A 203 GLN ARG GLU GLN THR SER GLY ARG LEU ASN ALA SER LEU SEQRES 6 A 203 ASP LYS SER SER GLY ARG SER THR LEU TYR ILE ALA ALA SEQRES 7 A 203 SER GLN PRO GLY ASP SER ALA THR TYR LEU CYS ALA VAL SEQRES 8 A 203 ARG PRO THR SER GLY GLY SER TYR ILE PRO THR PHE GLY SEQRES 9 A 203 ARG GLY THR SER LEU ILE VAL HIS PRO TYR ILE GLN ASN SEQRES 10 A 203 PRO ASP PRO ALA VAL TYR GLN LEU ARG ARG SER LYS SER SEQRES 11 A 203 SER ASP LYS SER VAL CYS LEU PHE THR ASP PHE ASP SER SEQRES 12 A 203 GLN THR ASN VAL SER GLN SER LYS ASP SER ASP VAL TYR SEQRES 13 A 203 ILE THR ASP LYS CYS VAL LEU ASP MET ARG SER MET ASP SEQRES 14 A 203 PHE LYS SER ASN SER ALA VAL ALA TRP SER ASN LYS SER SEQRES 15 A 203 ASP PHE ALA CYS ALA ASN ALA PHE ASN ASN SER ILE ILE SEQRES 16 A 203 PRO GLU ASP THR PHE PHE PRO SER SEQRES 1 B 241 GLY VAL THR GLN THR PRO LYS PHE GLN VAL LEU LYS THR SEQRES 2 B 241 GLY GLN SER MET THR LEU GLN CYS ALA GLN ASP MET ASN SEQRES 3 B 241 HIS GLU TYR MET SER TRP TYR ARG GLN ASP PRO GLY MET SEQRES 4 B 241 GLY LEU ARG LEU ILE HIS TYR SER VAL GLY ALA GLY ILE SEQRES 5 B 241 THR ASP GLN GLY GLU VAL PRO ASN GLY TYR ASN VAL SER SEQRES 6 B 241 ARG SER THR THR GLU ASP PHE PRO LEU ARG LEU LEU SER SEQRES 7 B 241 ALA ALA PRO SER GLN THR SER VAL TYR PHE CYS ALA SER SEQRES 8 B 241 SER TYR VAL GLY ASN THR GLY GLU LEU PHE PHE GLY GLU SEQRES 9 B 241 GLY SER ARG LEU THR VAL LEU GLU ASP LEU LYS ASN VAL SEQRES 10 B 241 PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SER GLU ALA SEQRES 11 B 241 GLU ILE SER HIS THR GLN LYS ALA THR LEU VAL CYS LEU SEQRES 12 B 241 ALA THR GLY PHE TYR PRO ASP HIS VAL GLU LEU SER TRP SEQRES 13 B 241 TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL CYS THR SEQRES 14 B 241 ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA LEU ASN ASP SEQRES 15 B 241 SER ARG TYR ALA LEU SER SER ARG LEU ARG VAL SER ALA SEQRES 16 B 241 THR PHE TRP GLN ASP PRO ARG ASN HIS PHE ARG CYS GLN SEQRES 17 B 241 VAL GLN PHE TYR GLY LEU SER GLU ASN ASP GLU TRP THR SEQRES 18 B 241 GLN ASP ARG ALA LYS PRO VAL THR GLN ILE VAL SER ALA SEQRES 19 B 241 GLU ALA TRP GLY ARG ALA ASP
FORMUL 3 HOH *243(H2 O)
HELIX 1 1 GLN A 81 SER A 85 5 5 HELIX 2 2 ARG A 167 ASP A 170 5 4 HELIX 3 3 ALA A 186 ASN A 192 5 7 HELIX 4 4 ALA B 81 THR B 85 5 5 HELIX 5 5 ASP B 114 VAL B 118 5 5 HELIX 6 6 SER B 129 GLN B 137 1 9 HELIX 7 7 ALA B 196 GLN B 200 1 5
SHEET 1 AA 5 VAL A 4 ILE A 7 0 SHEET 2 AA 5 LEU A 19 PHE A 25 -1 O ASN A 22 N ILE A 7 SHEET 3 AA 5 ARG A 72 ILE A 77 -1 O SER A 73 N CYS A 23 SHEET 4 AA 5 LEU A 62 ASP A 67 -1 O ASN A 63 N TYR A 76 SHEET 5 AA 5 GLU A 56 SER A 59 -1 O GLN A 57 N ALA A 64 SHEET 1 AB 5 ALA A 10 PRO A 14 0 SHEET 2 AB 5 THR A 108 HIS A 113 1 O SER A 109 N LEU A 11 SHEET 3 AB 5 ALA A 86 PRO A 94 -1 O ALA A 86 N LEU A 110 SHEET 4 AB 5 ILE A 30 GLN A 38 -1 N TYR A 31 O ARG A 93 SHEET 5 AB 5 LEU A 44 GLN A 51 -1 O THR A 45 N ARG A 37 SHEET 1 AC 4 ALA A 10 PRO A 14 0 SHEET 2 AC 4 THR A 108 HIS A 113 1 O SER A 109 N LEU A 11 SHEET 3 AC 4 ALA A 86 PRO A 94 -1 O ALA A 86 N LEU A 110 SHEET 4 AC 4 THR A 103 PHE A 104 -1 O THR A 103 N VAL A 92 SHEET 1 AD 4 ALA A 122 LEU A 126 0 SHEET 2 AD 4 SER A 135 THR A 140 -1 O VAL A 136 N LEU A 126 SHEET 3 AD 4 PHE A 171 SER A 180 -1 O ALA A 176 N PHE A 139 SHEET 4 AD 4 TYR A 157 ILE A 158 -1 O TYR A 157 N TRP A 179 SHEET 1 AE 4 ALA A 122 LEU A 126 0 SHEET 2 AE 4 SER A 135 THR A 140 -1 O VAL A 136 N LEU A 126 SHEET 3 AE 4 PHE A 171 SER A 180 -1 O ALA A 176 N PHE A 139 SHEET 4 AE 4 CYS A 162 MET A 166 -1 O CYS A 162 N SER A 175 SHEET 1 BA 4 VAL B 3 THR B 6 0 SHEET 2 BA 4 MET B 18 GLN B 24 -1 O GLN B 21 N THR B 6 SHEET 3 BA 4 LEU B 75 LEU B 77 -1 O LEU B 75 N LEU B 20 SHEET 4 BA 4 ASN B 64 VAL B 65 -1 O ASN B 64 N ARG B 76 SHEET 1 BB 6 PHE B 9 LYS B 13 0 SHEET 2 BB 6 SER B 107 LEU B 112 1 O ARG B 108 N GLN B 10 SHEET 3 BB 6 SER B 86 SER B 93 -1 O SER B 86 N LEU B 109 SHEET 4 BB 6 TYR B 30 ASP B 37 -1 O TYR B 30 N SER B 93 SHEET 5 BB 6 GLY B 41 GLY B 50 -1 O GLY B 41 N ASP B 37 SHEET 6 BB 6 ILE B 53 GLN B 56 -1 O ILE B 53 N GLY B 50 SHEET 1 BC 4 PHE B 9 LYS B 13 0 SHEET 2 BC 4 SER B 107 LEU B 112 1 O ARG B 108 N GLN B 10 SHEET 3 BC 4 SER B 86 SER B 93 -1 O SER B 86 N LEU B 109 SHEET 4 BC 4 PHE B 102 PHE B 103 -1 O PHE B 102 N SER B 92 SHEET 1 BD 7 GLU B 122 PHE B 126 0 SHEET 2 BD 7 LYS B 138 PHE B 148 -1 O VAL B 142 N PHE B 126 SHEET 3 BD 7 TYR B 186 SER B 195 -1 O TYR B 186 N PHE B 148 SHEET 4 BD 7 VAL B 168 THR B 170 -1 O CYS B 169 N ARG B 191 SHEET 5 BD 7 TYR B 186 SER B 195 -1 O ARG B 191 N CYS B 169 SHEET 6 BD 7 LEU B 175 LYS B 176 -1 O LEU B 175 N ALA B 187 SHEET 7 BD 7 TYR B 186 SER B 195 -1 O ALA B 187 N LEU B 175 SHEET 1 BE 4 LYS B 162 VAL B 164 0 SHEET 2 BE 4 VAL B 153 VAL B 159 -1 O TRP B 157 N VAL B 164 SHEET 3 BE 4 HIS B 205 PHE B 212 -1 O ARG B 207 N TRP B 158 SHEET 4 BE 4 GLN B 231 TRP B 238 -1 O GLN B 231 N PHE B 212
SSBOND 1 CYS A 23 CYS A 90 1555 1555 2.03 SSBOND 2 CYS A 137 CYS A 187 1555 1555 2.03 SSBOND 3 CYS A 162 CYS B 169 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 90 1555 1555 2.02 SSBOND 5 CYS B 143 CYS B 208 1555 1555 2.02
CISPEP 1 ILE A 7 PRO A 8 0 -0.10 CISPEP 2 THR B 6 PRO B 7 0 -0.24 CISPEP 3 TYR B 149 PRO B 150 0 0.07
CRYST1 42.991 60.295 82.641 90.00 89.54 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023261 0.000000 -0.000187 0.00000
SCALE2 0.000000 0.016585 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012101 0.00000